FI
Fosun International Portfolio holdings
AUM
$360M
1-Year Return
38.28%
This Quarter Return
-18.56%
1 Year Return
+38.28%
3 Year Return
+3.77%
5 Year Return
+27.59%
10 Year Return
+94.55%
AUM
$1.67B
AUM Growth
-$412M
(-20%)
Cap. Flow
+$50M
Cap. Flow
% of AUM
2.99%
Top 10 Holdings %
Top 10 Hldgs %
54.47%
Holding
343
New
97
Increased
69
Reduced
59
Closed
44
Top Buys
| 1 |
Vipshop
VIPS
|
$16.5M |
| 2 |
SDRL
Seadrill Limited Common Stock
SDRL
|
$14.4M |
| 3 |
DigitalBridge
DBRG
|
$12.9M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$10.5M |
| 5 |
MakeMyTrip
MMYT
|
$5.07M |
Top Sells
| 1 |
Brookdale Senior Living
BKD
|
$46M |
| 2 |
Bath & Body Works
BBWI
|
$18.6M |
| 3 |
Bilibili
BILI
|
$13M |
| 4 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
$10.8M |
| 5 |
Gilead Sciences
GILD
|
$9.52M |
Sector Composition
| 1 | Healthcare | 39.38% |
| 2 | Financials | 7.66% |
| 3 | Consumer Discretionary | 5.31% |
| 4 | Communication Services | 3.82% |
| 5 | Industrials | 2.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Mondelez International
MDLZ
$79.6B
| $656K | 0.04% |
16,400
-5,000
| -23% | -$200K |
|
177
Lexicon Pharmaceuticals
LXRX
$392M
| $639K | 0.04% |
+100,621
| New | +$639K |
|
|
MDCO
178
DELISTED
Medicines Co
MDCO
| $636K | 0.04% |
+34,000
| New | +$636K |
|
179
Amgen
AMGN
$153B
| $634K | 0.04% |
3,330
| – | – |
|
180
AngloGold Ashanti
AU
$30B
| $626K | 0.04% |
50,000
| – | – |
|
181
Citigroup
C
$176B
| $621K | 0.04% |
12,000
-535
| -4% | -$27.7K |
|
182
Intuit
INTU
$188B
| $620K | 0.04% |
3,145
| – | – |
|
|
BLRX
183
BioLineRX
BLRX
$15.2M
| $611K | 0.04% |
2,262
| – | – |
|
184
Protagonist Therapeutics
PTGX
$3.75B
| $609K | 0.04% |
+96,513
| New | +$609K |
|
185
Estee Lauder
EL
$32.1B
| $605K | 0.04% |
4,710
-7,390
| -61% | -$949K |
|
186
First Majestic Silver
AG
$4.47B
| $596K | 0.04% |
100,000
| – | – |
|
187
Morgan Stanley
MS
$237B
| $596K | 0.04% |
+15,041
| New | +$596K |
|
188
Biogen
BIIB
$20.7B
| $589K | 0.04% |
2,000
| – | – |
|
189
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $576K | 0.03% |
+65,500
| New | +$576K |
|
|
STML
190
DELISTED
Stemline Therapeutics, Inc.
STML
| $572K | 0.03% |
+58,000
| New | +$572K |
|
191
Infosys
INFY
$67.8B
| $566K | 0.03% |
+59,930
| New | +$566K |
|
192
Las Vegas Sands
LVS
$36.9B
| $557K | 0.03% |
10,900
-9,100
| -46% | -$465K |
|
193
Arrowhead Research
ARWR
$4.03B
| $551K | 0.03% |
+46,000
| New | +$551K |
|
|
B
194
Barrick Mining Corporation
B
$48.3B
| $548K | 0.03% |
40,000
-45,000
| -53% | -$617K |
|
|
BOLD
195
DELISTED
Audentes Therapeutics, Inc
BOLD
| $546K | 0.03% |
+26,000
| New | +$546K |
|
196
IAMGOLD
IAG
$5.69B
| $545K | 0.03% |
150,000
+50,000
| +50% | +$182K |
|
|
TBIO
197
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $545K | 0.03% |
+74,000
| New | +$545K |
|
198
Deckers Outdoor
DECK
$17.9B
| $544K | 0.03% |
25,020
| – | – |
|
199
General Motors
GM
$55.5B
| $543K | 0.03% |
16,000
-2,000
| -11% | -$67.9K |
|
200
Danaher
DHR
$143B
| $538K | 0.03% |
5,978
-13,988
| -70% | -$1.26M |
|